Table 6.
Patients’ characteristics
| eGFR | Age (years) | SUA (mmol/L) | 25-OH-VitD (ng/mL) | Glycemia (mmol/L) | HbA1c (%) | Triglycerides (mmol/L) | Total cholesterol (mmol/L) | LDL (mmol/L) |
|---|---|---|---|---|---|---|---|---|
| < 90 mL/min/1.73 m2 | 41.64 ± 10.39 | 0.38 ± 0.10 | 26.85 ± 13.23 | 5.29 ± 1.31 | 5.98 ± 1.02 | 1.31 ± 0.64 | 4.50 ± 1.05 | 2.21 ± 0.92 |
| 90–119 mL/min/1.73 m2 | 34.63 ± 10.80 | 0.34 ± 0.08 | 25.55 ± 9.70 | 5.41 ± 2.09 | 5.69 ± 0.93 | 1.07 ± 0.60 | 3.90 ± 1.02 | 1.97 ± 0.79 |
| ≥ 120 mL/min/1.73 m2 | 28.54 ± 10.52 | 0.32 ± 0.09 | 21.96 ± 7.80 | 5.29 ± 1.31 | 5.98 ± 1.02 | 0.89 ± 0.39 | 3.41 ± 1.13 | 1.72 ± 0.89 |
| p value (using ANOVA) | 0.001 | 0.005 | 0.197 | 0.671 | 0.146 | 0.005 | 0.001 | 0.040 |
Lipid and Metabolic profile in relation to eGFR and age in CF patients. Data are shown as Average ± SD
CF cystic fibrosis, eGFR estimated Glomerular Filtration Rate, LDL low-density, SUA Serum Uric Acid, 25-OH-VitD 25-hydroxy-vitamin D, HbA1c hemoglobin A1c. lipoprotein cholesterol, CF cystic fibrosis